Senior insider sale
EVP, General Counsel, Corp Sec at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$77.1K
8.22K shares
What this filing means
DE VERNEUIL VANINA plans to sell 8.22K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $77.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/2/2024ACC: 0001950047-24-009340
Officer· EVP, General Counsel, Corp Sec
Since Feb 2026
8.22K
Shares to sell
$77.1K
Approx. market value
76.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Shares Purchased through Employee Stock Purchase Plan
Cash
11/30/2024
76.00Total acquired76.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/30/2024 | Shares Purchased through Employee Stock Purchase Plan Cash | 76.00 | — |
| Total | 76.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.40K
Market value
$44.3K
11/6/2024
—Completed
Units to sell
2.35K
Market value
$22.1K
11/5/2024
—Completed
Units to sell
1.40K
Market value
$10.0K
11/1/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
76.00
Market value
$624.73
12/2/2024
Total
Units
8.22K
Value
$77.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/6/2024 | 4.40K | $44.3K | — | Completed |
11/5/2024 | 2.35K | $22.1K | — | Completed |
11/1/2024 | 1.40K | $10.0K | — | Completed |
| Planned — Approximate Date | ||||
12/2/2024 | 76.00 | $624.73 | NASDAQ | Planned |
| Total | 8.22K | $77.1K | ||